LAUSR

1 Chren MM, Lasek RJ, Quinn LM et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107:707–13. 2 Revuz JE, Canoui-Poitrine F, Wolkenstein P et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case– control studies. J Am Acad Dermatol 2008; 59:596–601. 3 Jemec GBE. Hidradenitis suppurativa. N Engl J Med 2012; 366:158– 64. 4 Wolkenstein P, Loundou A, Barrau K et al. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2007; 56:621–3. 5 Janse IC, Deckers IE, van der Maten AD et al. Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study. Br J Dermatol 2017; 176:1042–7. 6 Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009; 60:539–61. 7 Diepgen TL, Eysenbach G. Digital images in dermatology and the Dermatology Online Atlas on the World Wide Web. J Dermatol 1998; 25:782–7.